- Book
- April 2018
- 264 Pages
- Book
- March 2018
- 1134 Pages
- Book
- March 2018
- 440 Pages
- Book
- December 2013
- 548 Pages
- Book
- August 2013
- 352 Pages
- Book
- November 2011
- 594 Pages
- Book
- August 2011
- 466 Pages
- Book
- August 2010
- 656 Pages
- Book
- July 2010
- 376 Pages
- Book
- May 2008
- 440 Pages
- Book
- December 2022
- 336 Pages
- Book
- May 2021
- 544 Pages
- Book
- June 2019
- 684 Pages
- Book
- February 2018
- 480 Pages
- Book
- January 2024
- 448 Pages
- Book
- January 2024
- 272 Pages
- Book
- February 2022
- 1008 Pages
- Book
- January 2022
- 448 Pages

The Biomolecules market is a subset of the biotechnology industry that focuses on the production and use of biomolecules. These molecules are typically proteins, nucleic acids, carbohydrates, and lipids, and are used in a variety of applications, such as drug discovery, diagnostics, and therapeutics. The market is driven by advances in biotechnology, which have enabled the development of new and improved biomolecules. Additionally, the increasing demand for personalized medicine and the development of new technologies, such as gene editing, are expected to drive the growth of the market.
The Biomolecules market is highly competitive, with a number of large companies, such as Amgen, Merck, and Novartis, as well as smaller companies, such as Genentech and Biogen, competing for market share. Additionally, there are a number of start-ups and research institutions that are developing new technologies and products. Show Less Read more